Virax Biolabs Group (Virax Biolabs Group) EV-to-Revenue : -36.79 (As of May. 19, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Virax Biolabs Group's enterprise value is $-2.94 Mil. Virax Biolabs Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $0.08 Mil. Therefore, Virax Biolabs Group's EV-to-Revenue for today is -36.79.

The historical rank and industry rank for Virax Biolabs Group's EV-to-Revenue or its related term are showing as below:

VRAX' s EV-to-Revenue Range Over the Past 10 Years
Min: -902.65 Med: -103.84 Max: 1001.52
Current: -36.79

During the past 4 years, the highest EV-to-Revenue of Virax Biolabs Group was 1001.52. The lowest was -902.65. And the median was -103.84.

VRAX's EV-to-Revenue is ranked better than
98.66% of 1044 companies
in the Biotechnology industry
Industry Median: 8.205 vs VRAX: -36.79

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-19), Virax Biolabs Group's stock price is $0.8395. Virax Biolabs Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.44. Therefore, Virax Biolabs Group's PS Ratio for today is 1.93.

Virax Biolabs Group EV-to-Revenue Historical Data

The historical data trend for Virax Biolabs Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group EV-to-Revenue Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

153.61

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial			-	-	-	153.61	-

Competitive Comparison of Virax Biolabs Group's EV-to-Revenue

For the Biotechnology subindustry, Virax Biolabs Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virax Biolabs Group's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's EV-to-Revenue falls into.

Virax Biolabs Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Virax Biolabs Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-2.943	/	0.08
	=	-36.79

Virax Biolabs Group's current Enterprise Value is $-2.94 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Virax Biolabs Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $0.08 Mil.

Virax Biolabs Group (NAS:VRAX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Virax Biolabs Group's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.8395	/	0.435
	=	1.93

Virax Biolabs Group's share price for today is $0.8395.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was $0.44.

Virax Biolabs Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group (Virax Biolabs Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 North Audley Street, London, GBR, W1K 6LX

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.